AMREP CEO awarded 8,700 restricted stock shares

Rhea-AI Filing Summary

AMREP CORP. President and CEO Christopher V. Vitale reported an acquisition of 8,700 shares of common stock as a grant of restricted stock under the AMREP Corporation 2016 Equity Compensation Plan at $0.00 per share.

The restricted stock vests in three equal installments of 2,900 shares on July 13, 2027, July 13, 2028, and July 13, 2029, subject to his continued employment on each vesting date. Following this award, Vitale directly holds 125,900 shares of AMREP common stock.

Insider Trade Summary

Grant/Award: 8,700 shares

Grant/Award 1 txn

Insider Vitale Christopher V

Role President and CEO

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1	8,700	$0.00	$0.00

Holdings After Transaction: Common Stock — 125,900 shares (Direct)

Footnotes (1)

1. F1. Grant of restricted stock under the AMREP Corporation 2016 Equity Compensation Plan. The restricted stock will vest as follows: 2,900 shares on July 13, 2027, 2,900 shares on July 13, 2028 and 2,900 shares on July 13, 2029, subject to the continued employment of Mr. Vitale by AMREP Corporation on each vesting date.

Key Figures

Restricted stock grant: 8,700 shares Grant price per share: $0.00 Post-transaction holdings: 125,900 shares +3 more

6 metrics

Restricted stock grant 8,700 shares Grant of restricted common stock on July 13, 2026 to Christopher V. Vitale

Grant price per share $0.00 Price per share for the restricted stock award under the 2016 Equity Compensation Plan

Post-transaction holdings 125,900 shares Total AMREP common shares directly held by Christopher V. Vitale after the grant

First vesting tranche 2,900 shares Restricted stock vesting on July 13, 2027, subject to continued employment

Second vesting tranche 2,900 shares Restricted stock vesting on July 13, 2028, subject to continued employment

Third vesting tranche 2,900 shares Restricted stock vesting on July 13, 2029, subject to continued employment

Key Terms

restricted stock, Equity Compensation Plan, vesting, continued employment

4 terms

restricted stock financial

"Grant of restricted stock under the AMREP Corporation 2016 Equity Compensation Plan."

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Equity Compensation Plan financial

"Grant of restricted stock under the AMREP Corporation 2016 Equity Compensation Plan."

A plan by which a company gives employees, directors or contractors ownership or the right to buy ownership in the company through stock, options or similar awards — think of promising slices of the company pie as part of someone's pay. It matters to investors because these awards can change the number of shares outstanding, affect reported profits and influence management’s decisions; large or generous plans can dilute existing holders and alter incentives over time.

vesting financial

"The restricted stock will vest as follows: 2,900 shares on July 13, 2027..."

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

continued employment financial

"subject to the continued employment of Mr. Vitale by AMREP Corporation on each vesting date."

Continued employment means that an individual remains in their current job without interruption. For investors, it signals stability and ongoing work that can affect company performance and future prospects. Like a steady heartbeat for a business, sustained employment helps ensure consistent operations and financial health.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did AMREP CORP. (AXR) report for Christopher V. Vitale?

AMREP CORP. reported that President and CEO Christopher V. Vitale received a grant of 8,700 shares of restricted common stock. The award was made at $0.00 per share under the company’s 2016 Equity Compensation Plan as part of his compensation.

How many AMREP CORP. (AXR) shares did Christopher V. Vitale acquire in this Form 4 filing?

Christopher V. Vitale acquired 8,700 shares of AMREP common stock through a restricted stock grant. These shares are not an open-market purchase but part of an equity compensation award under the 2016 Equity Compensation Plan at $0.00 per share.

What is the vesting schedule of the 8,700 restricted AMREP CORP. (AXR) shares granted to Vitale?

The 8,700 restricted shares will vest in three equal tranches of 2,900 shares each on July 13, 2027, July 13, 2028, and July 13, 2029, subject to Christopher V. Vitale’s continued employment with AMREP on each respective vesting date.

How many AMREP CORP. (AXR) shares does Christopher V. Vitale hold after this transaction?

After the restricted stock grant, Christopher V. Vitale directly holds 125,900 shares of AMREP CORP. common stock. This total reflects his direct ownership position immediately following the reported equity compensation award.

Was the AMREP CORP. (AXR) transaction for Christopher V. Vitale an open-market buy or a compensation grant?

The transaction was a compensation grant, coded as an award (A), not an open-market purchase. Vitale received 8,700 restricted shares at $0.00 per share under the AMREP Corporation 2016 Equity Compensation Plan.

What conditions apply to the vesting of Christopher V. Vitale’s AMREP CORP. (AXR) restricted stock grant?

Each vesting tranche of 2,900 shares is subject to continued employment. Vitale must remain employed by AMREP Corporation on July 13 in 2027, 2028, and 2029, respectively, for the corresponding restricted shares to vest.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/14/2026 - 04:45 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Vitale Christopher V

(Last) (First) (Middle)

C/O AMREP CORPORATION

850 WEST CHESTER PIKE, SUITE 205

(Street)

HAVERTOWN PENNSYLVANIA 19083

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AMREP CORP. [ AXR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/13/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock(1)	07/13/2026		A		8,700	A	$0	125,900	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of restricted stock under the AMREP Corporation 2016 Equity Compensation Plan. The restricted stock will vest as follows: 2,900 shares on July 13, 2027, 2,900 shares on July 13, 2028 and 2,900 shares on July 13, 2029, subject to the continued employment of Mr. Vitale by AMREP Corporation on each vesting date.

	/s/ Christopher V. Vitale	07/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)